Laura Clague
CIK 1388773 · Chief Financial Officer · last filed 2023-06-16
Laura Clague is a Chief Financial Officer who has filed 60 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for LAB, was dated Jun 16, 2023. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.56M
7
60
-$2.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAB | Director | 104,791 | $0.79 | $83.3K | $0 | 2 | 2023-06-16 |
| TVTX | Chief Financial Officer | 35,655 | $55.91 | $1.99M | -$972.2K | 12 | 2022-05-12 |
| GNSS | Director | 286,311 | $1.69 | $483.9K | -$83.5K | 6 | 2022-04-27 |
| STANDARD BIOTOOLS INC. (FLDM) Delisted | Director | 47,501 | $3.71 | $176.2K | $0 | 5 | 2021-05-27 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Chief Financial Officer | 19,473 | — | — | -$955.7K | 21 | 2020-11-17 |
| Genasys Inc. (LRAD) Delisted | Director | 97,600 | — | — | -$14.5K | 11 | 2019-03-20 |
| Genasys Inc. (ATCO) Delisted | Director | 1,000 | $15.48 | $15.5K | $870 | 3 | 2008-12-15 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-16 | LAB | Grant (A) | +26,376 | $0 | EDGAR |
| 2022-06-17 | LAB | Grant (A) | +30,914 | $0 | EDGAR |
| 2022-05-12 | TVTX | Sell (S) | −2,200 | -$47.3K | EDGAR |
| 2022-04-27 | GNSS | Exer (M) | +50,000 | $66.5K | EDGAR |
| 2022-03-17 | GNSS | Grant (A) | +30,000 | $0 | EDGAR |
| 2022-02-24 | GNSS | Mixed | +6,284 | $132 | EDGAR |
| 2022-02-02 | TVTX | Mixed | +8,602 | -$33.9K | EDGAR |
| 2022-01-26 | TVTX | Sell (S) | −2,063 | -$51.5K | EDGAR |
| 2022-01-12 | TVTX | Mixed | — | -$205.5K | EDGAR |
| 2021-08-17 | TVTX | Mixed | +3,093 | -$24.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.